Screener
Catalyst Biosciences CBIO Q4 2025 Annual earnings
Reported February 26, 2026 · After market close
Revenue$10.8MBeat by $844.0K
EPS-$4.01Miss by $1.79
Revenue estimate$10.0M
EPS estimate-$2.22
Next report
Date not yet announcedVersus estimates
Revenue
Diluted EPS
FAQ
- When did Catalyst Biosciences report Q4 2025 earnings?
- Catalyst Biosciences (CBIO) reported Q4 2025 earnings on February 26, 2026 after market close.
- What were Catalyst Biosciences's Q4 2025 revenue and EPS?
- Catalyst Biosciences reported revenue of $10.8M and eps of $-4.01 for Q4 2025.
- Did Catalyst Biosciences beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $10.0M by $844.0K. EPS missed the consensus estimate of $-2.22 by $1.79.
- How did Catalyst Biosciences's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 19949.6% from $54.1K a year earlier and eps declined 3545.5% from $-0.11.
- Where can I find Catalyst Biosciences's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001628280-26-011988) and the 10-K periodic report (0001628280-26-011983) directly on SEC EDGAR. The filing index links above go to sec.gov.
